359 related articles for article (PubMed ID: 17916208)
21. Effects of etanercept on urine neopterin levels in patients with psoriasis in a controlled, open-label study.
Koc E; Tunca M; Akgul EO; Akar A; Kurt Y; Kurumlu Z; Erbil K; Kilic S
J Dermatol; 2009 Apr; 36(4):191-6. PubMed ID: 19348656
[TBL] [Abstract][Full Text] [Related]
22. Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension.
van de Kerkhof PC; Segaert S; Lahfa M; Luger TA; Karolyi Z; Kaszuba A; Leigheb G; Camacho FM; Forsea D; Zang C; Boussuge MP; Paolozzi L; Wajdula J
Br J Dermatol; 2008 Nov; 159(5):1177-85. PubMed ID: 18673365
[TBL] [Abstract][Full Text] [Related]
23. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
[TBL] [Abstract][Full Text] [Related]
24. Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis.
Luger TA; Barker J; Lambert J; Yang S; Robertson D; Foehl J; Molta CT; Boggs R
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):896-904. PubMed ID: 19453794
[TBL] [Abstract][Full Text] [Related]
25. Economic evaluation of etanercept in the management of chronic plaque psoriasis.
Lloyd A; Reeves P; Conway P; Reynolds A; Baxter G
Br J Dermatol; 2009 Feb; 160(2):380-6. PubMed ID: 18808413
[TBL] [Abstract][Full Text] [Related]
26. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.
Hijnen D; De Bruin-Weller M; Oosting B; Lebre C; De Jong E; Bruijnzeel-Koomen C; Knol E
J Allergy Clin Immunol; 2004 Feb; 113(2):334-40. PubMed ID: 14767451
[TBL] [Abstract][Full Text] [Related]
27. Comparison of clinical and pharmacokinetic profiles of etanercept 25 mg twice weekly and 50 mg once weekly in patients with psoriasis.
Elewski B; Leonardi C; Gottlieb AB; Strober BE; Simiens MA; Dunn M; Jahreis A
Br J Dermatol; 2007 Jan; 156(1):138-42. PubMed ID: 17199580
[TBL] [Abstract][Full Text] [Related]
28. CTACK/CCL27 accelerates skin regeneration via accumulation of bone marrow-derived keratinocytes.
Inokuma D; Abe R; Fujita Y; Sasaki M; Shibaki A; Nakamura H; McMillan JR; Shimizu T; Shimizu H
Stem Cells; 2006 Dec; 24(12):2810-6. PubMed ID: 16931770
[TBL] [Abstract][Full Text] [Related]
29. CCL27 is downregulated by interferon gamma via epidermal growth factor receptor in normal human epidermal keratinocytes.
Karakawa M; Komine M; Hanakawa Y; Tsuda H; Sayama K; Tamaki K; Ohtsuki M
J Cell Physiol; 2014 Dec; 229(12):1935-45. PubMed ID: 24710735
[TBL] [Abstract][Full Text] [Related]
30. Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial.
Gisondi P; Del Giglio M; Cotena C; Girolomoni G
Br J Dermatol; 2008 Jun; 158(6):1345-9. PubMed ID: 18410408
[TBL] [Abstract][Full Text] [Related]
31. Serum and tissue CTACK/CCL27 chemokine levels in early mycosis fungoides may be correlated with disease-free survival following treatment with interferon alfa and psoralen plus ultraviolet A therapy.
Goteri G; Rupoli S; Campanati A; Zizzi A; Picardi P; Cardelli M; Giantomassi F; Canafoglia L; Marchegiani F; Mozzicafreddo G; Brandozzi G; Stramazzotti D; Ganzetti G; Lisa R; Simonetti O; Offidani A; Federici I; Filosa G; Leoni P
Br J Dermatol; 2012 May; 166(5):948-52. PubMed ID: 22233400
[TBL] [Abstract][Full Text] [Related]
32. Etanercept plus narrowband ultraviolet B phototherapy of psoriasis is more effective than etanercept monotherapy at 6 weeks.
Gambichler T; Tigges C; Scola N; Weber J; Skrygan M; Bechara FG; Altmeyer P; Kreuter A
Br J Dermatol; 2011 Jun; 164(6):1383-6. PubMed ID: 21466532
[TBL] [Abstract][Full Text] [Related]
33. Etanercept for psoriasis: two case reports.
Fidalgo A; Baptista J; Rocha Páris F; Caldas Lopes L; Ferreira A
Int J Clin Pharmacol Res; 2005; 25(4):159-63. PubMed ID: 16402631
[TBL] [Abstract][Full Text] [Related]
34. Etanercept combined with methotrexate for high-need psoriasis.
Driessen RJ; van de Kerkhof PC; de Jong EM
Br J Dermatol; 2008 Aug; 159(2):460-3. PubMed ID: 18547310
[TBL] [Abstract][Full Text] [Related]
35. Tumor necrosis factor-alpha-induced CTACK/CCL27 (cutaneous T-cell-attracting chemokine) production in keratinocytes is controlled by nuclear factor kappaB.
Vestergaard C; Johansen C; Otkjaer K; Deleuran M; Iversen L
Cytokine; 2005 Jan; 29(2):49-55. PubMed ID: 15598438
[TBL] [Abstract][Full Text] [Related]
36. Increased cutaneous T-cell-attracting chemokine levels in sera from patients with systemic sclerosis.
Hayakawa I; Hasegawa M; Matsushita T; Yanaba K; Kodera M; Komura K; Takehara K; Sato S
Rheumatology (Oxford); 2005 Jul; 44(7):873-8. PubMed ID: 15797972
[TBL] [Abstract][Full Text] [Related]
37. Puerto Rico psoriasis study group: efficacy and safety of etanercept.
González-Chavez JR; Berlingeri-Ramos AC; Sánchez Casiano MA
J Drugs Dermatol; 2005; 4(6):735-9. PubMed ID: 16302559
[TBL] [Abstract][Full Text] [Related]
38. Etanercept: efficacy and safety.
Jiménez-Puya R; Gómez-García F; Amorrich-Campos V; Moreno-Giménez JC
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):402-5. PubMed ID: 19210697
[TBL] [Abstract][Full Text] [Related]
39. Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome.
Driessen RJ; Boezeman JB; van de Kerkhof PC; de Jong EM
Br J Dermatol; 2009 Mar; 160(3):670-5. PubMed ID: 19210502
[TBL] [Abstract][Full Text] [Related]
40. TARC augments TNF-alpha-induced CTACK production in keratinocytes.
Vestergaard C; Johansen C; Christensen U; Just H; Hohwy T; Deleuran M
Exp Dermatol; 2004 Sep; 13(9):551-7. PubMed ID: 15335355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
